Cardio-Oncology, 2025
Discovery of plasma proteins and metabolites associated with left ventricular cardiac dysfunction in pan-cancer patients

Lal J., Fang M., Hussain M. et al.

Brain Communications, 2025
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis

van Eijk R., Steyn F., Janse van Mantgem M. et al.

Arthritis Research & Therapy, 2025
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype

Xu X., Qiu T., Sun K. et al.

Diabetes Care, 2025
Proteomic and Metabolomic Signatures in Prediabetes Progressing to Diabetes or Reversing to Normoglycemia Within 1 Year

Barovic M., Hahn J., Heinrich A. et al.

Archives of Toxicology, 2024
Pulmonary exposure to renewable diesel exhaust particles alters protein expression and toxicity profiles in bronchoalveolar lavage fluid and plasma of mice

McCarrick S., Malmborg V., Gren L. et al.

EPMA Journal, 2024
Mendelian randomization reveals predictive, preventive, and personalized insights into inflammatory bowel disease: the role of gut microbiome and circulating inflammatory proteins

Zhao W., Li S., Li Q. et al.

Journal of Translational Medicine, 2024
Shedding of membrane complement inhibitors CD59 and CD46 into the circulation is associated with poor prognosis in acute coronary syndrome patients: a cohort study

Zhong B., King B., Waziri H. et al.

BMC Medicine, 2024
Non-fermented and fermented milk intake in relation to risk of ischemic heart disease and to circulating cardiometabolic proteins in swedish women and men: Two prospective longitudinal cohort studies with 100,775 participants

Michaëlsson K., Lemming E., Larsson S. et al.

Journal of Inflammation Research, 2024
Successful Treatment of Pediatric Generalized Pustular Psoriasis (GPP) with Spesolimab: 5 Case Reports and Evaluations of Circulating IL-36 Levels

Chen Y., Wang Z., Liang Y. et al.

Gut Microbes, 2024
Exercise-changed gut mycobiome as a potential contributor to metabolic benefits in diabetes prevention: an integrative multi-omics study

Wang Y., Chen J., Ni Y. et al.

Journal of Cellular and Molecular Medicine, 2024
Causal association of circulating inflammatory proteins on neurodegenerative diseases: Insights from a mendelian randomization study

Lin W., Wu X., Ou G.

Journal of Hematology & Oncology, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas

Guegan J., El Ghazzi N., Vibert J. et al.

Cytokine, 2024
Causal relationship between circulating inflammatory proteins and risk of different types of encephalitis: A two-sample Mendelian randomization study

Yang S., Liu Y., Wang S. et al.

Nature Communications, 2024
Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response

Rahman M., Bissa M., Scinto H. et al.

Scientific Reports, 2024
The mediating effect of circulating inflammatory proteins on the relationship between gut microbiota and FD: a bidirectional Mendelian randomization study

Li L., Fu M., Chen F. et al.

Cancer Epidemiology, Biomarkers & Prevention, 2024
Plasma Ghrelin and Risks of Sex-Specific, Site-Specific, and Early-Onset Colorectal Cancer: A Mendelian Randomization Analysis

Hazelwood E., Lopez Manzano C., Vincent E. et al.

Translational Psychiatry, 2024
Serum cytokines and inflammatory proteins in individuals with heroin use disorder: potential mechanistically based biomarkers for diagnosis

Butelman E., Huang Y., Cathomas F. et al.

Communications Biology, 2024
A serum B-lymphocyte activation signature is a key distinguishing feature of the immune response in sarcoidosis compared to tuberculosis

Putera I., Schrijver B., Kolijn P. et al.

ESC Heart Failure, 2024
Elevated carbohydrate antigen 125 (CA125) is associated with incident heart failure and mortality in acute coronary syndrome

Yndigegn T., Gu T., Grufman H. et al.

Nature Cancer, 2024
A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma

Dimitriou F., Cheng P., Saltari A. et al.